Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:238-242

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, Y.
Right arrow Articles by Davidson, B. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, Y.
Right arrow Articles by Davidson, B. L.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Gene therapy
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:238.)
© 2001 American Heart Association, Inc.


Vascular Biology

Vascular Cell Adhesion Molecule-1 Augments Adenovirus-Mediated Gene Transfer

Yi Chu; Donald D. Heistad; Myron I. Cybulsky; Beverly L. Davidson

From the Departments of Internal Medicine (Y.C., D.D.H., B.L.D.), Neurology (B.L.D.), and Pharmacology (D.D.H.), the Cardiovascular Center (D.D.H.), the Center on Aging (D.D.H.), and the Program in Gene Therapy (D.D.H., B.L.D.), University of Iowa College of Medicine, Iowa City; the Veterans Administration Medical Center (D.D.H.), Iowa City, Iowa; and the Department of Laboratory Medicine and Pathobiology (M.I.C.), The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada.

Correspondence to Beverly L. Davidson, PhD, Roy J. Carver Associate Professor in Internal Medicine and Neurology, Director, Gene Transfer Vector Core, University of Iowa College of Medicine, Iowa City, IA 52242. E-mail beverly-davidson{at}uiowa.edu

Abstract—We have reported that adenovirus-mediated gene transfer is augmented in the endothelium of atherosclerotic blood vessels. We observed that vascular cell adhesion molecule-1 (VCAM-1) shares some homology with the coxsackievirus and adenovirus receptor. Because VCAM-1 is upregulated on atherosclerotic endothelial cells, we hypothesized that VCAM-1 may act as an auxiliary receptor to augment adenovirus-mediated gene transfer. To test this hypothesis, stable NIH 3T3 cell lines that constitutively express VCAM-1 on the cell surface were generated. Recombinant adenovirus 5 (Ad5), which contains the reporter ß-galactosidase gene, was used to compare Ad5 infection in VCAM-1+ and parental NIH 3T3 cells. Total ß-galactosidase activity and the number of transgene-positive cells were 6- to 10-fold and 5-fold higher, respectively, in VCAM-1+ than in VCAM-1- cells. Ad5 binding to VCAM-1+ cells was increased by 3-fold over VCAM-1- cells. Soluble VCAM-1 protein, present during infection or viral binding, reduced ß-galactosidase activity in VCAM-1+ cells in a dose-dependent manner. Taken together, we conclude that VCAM-1 can mediate adenovirus binding and infection. This may explain, in part, the previous finding that adenovirus-mediated gene transfer is augmented in atherosclerotic arteries.


Key Words: vascular cell adhesion molecule-1 • coxsackie and adenovirus receptor • adenovirus-mediated gene transfer • atherosclerosis




This article has been cited by other articles:


Home page
J. Virol.Home page
M. I. Jonsson, A. E. Lenman, L. Frangsmyr, C. Nyberg, M. Abdullahi, and N. Arnberg
Coagulation Factors IX and X Enhance Binding and Infection of Adenovirus Types 5 and 31 in Human Epithelial Cells
J. Virol., April 15, 2009; 83(8): 3816 - 3825.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Lecollinet, F. Gavard, M. J. E. Havenga, O. B. Spiller, A. Lemckert, J. Goudsmit, M. Eloit, and J. Richardson
Improved Gene Delivery to Intestinal Mucosa by Adenoviral Vectors Bearing Subgroup B and D Fibers
J. Virol., March 15, 2006; 80(6): 2747 - 2759.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Marttila, D. Persson, D. Gustafsson, M. K. Liszewski, J. P. Atkinson, G. Wadell, and N. Arnberg
CD46 Is a Cellular Receptor for All Species B Adenoviruses except Types 3 and 7
J. Virol., November 15, 2005; 79(22): 14429 - 14436.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Zhang and J. M. Bergelson
Adenovirus Receptors
J. Virol., October 1, 2005; 79(19): 12125 - 12131.
[Full Text] [PDF]


Home page
J. Virol.Home page
A. Segerman, J. P. Atkinson, M. Marttila, V. Dennerquist, G. Wadell, and N. Arnberg
Adenovirus Type 11 Uses CD46 as a Cellular Receptor
J. Virol., September 1, 2003; 77(17): 9183 - 9191.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Segerman, N. Arnberg, A. Erikson, K. Lindman, and G. Wadell
There Are Two Different Species B Adenovirus Receptors: sBAR, Common to Species B1 and B2 Adenoviruses, and sB2AR, Exclusively Used by Species B2 Adenoviruses
J. Virol., December 20, 2002; 77(2): 1157 - 1162.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Arnberg, P. Pring-Akerblom, and G. Wadell
Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor on Chang C Cells
J. Virol., July 29, 2002; 76(17): 8834 - 8841.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. J. E. Havenga, A. A. C. Lemckert, O. J. A. E. Ophorst, M. van Meijer, W. T. V. Germeraad, J. Grimbergen, M. A. van den Doel, R. Vogels, J. van Deutekom, A. A. M. Janson, et al.
Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease
J. Virol., March 27, 2002; 76(9): 4612 - 4620.
[Abstract] [Full Text] [PDF]